Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Exhibit 1.1
- 3.1 Exhibit 3.1
- 3.3 Exhibit 3.3
- 3.4 Exhibit 3.4
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 5.1 Exhibit 5.1
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
Associated filings
- 30 Jul 21 424B4 Prospectus supplement with pricing info
- 30 Jul 21 EFFECT Notice of effectiveness
- 28 Jul 21 S-1/A IPO registration (amended)
-
26 Jul 21 S-1/A IPO registration (amended)
- 9 Jul 21 S-1 IPO registration
IMRX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to the Registration Statement (No. 333-257791) on Form S-1 of Immuneering Corporation of our report dated May 13, 2021, except for the stock split described in Note 13 as to which the date is July 23, 2021, relating to the consolidated financial statements of Immuneering Corporation Inc. and its subsidiary, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the heading "Experts" in such Prospectus.
/s/ RSM US LLP
Boston, Massachusetts
July 23, 2021